Publications by authors named "David Irvine"

Claim this Profile
P
Patient and Caregiver Experiences of CAR T Cell Therapy for Blood Cancer in the UK: A Qualitative Study.
Christel McMullan, Melanie J Calvert, Sarah E Hughes, Lester Pyatt, Bernie Kern, David Irvine

Patient· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.
Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias Menne, David A Irvine

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative autofluorescence analysis of silicon nitride and tantalum pentoxide waveguides at 532 nm.
David A Irvine, Ephrata Zelleke, Aaron T Schreyer, William D Houck, Mark A Foster

Opt Express· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK.
Tasneem Pirani, Anthony Wilson, David Brealey, Ryan Low, Suzanne O'Neill, David Irvine

Br J Anaesth· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.
Kathleen P L Cheok, Amy A Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, David Irvine

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.
Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma.
Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, Aravind Ramakrishnan, Yiyun Zhang, David Irvine

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.
Kathleen P L Cheok, Amy A Kirkwood, Tobias Menne, Eleni Tholouli, Sridhar Chaganti, David Irvine

Leuk Lymphoma· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Claire Roddie, Juliana Dias, Maeve A O'Reilly, Mahnaz Abbasian, Amaia Cadinanos-Garai, David Irvine

J Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of CAR-T cell therapy on apheresis services: a Scottish perspective.
Gillian A Horne, Jennifer Laird, Anne Louise Latif, David Irvine, Matthew Wilson

J Clin Apher· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Ross Kinstrie, Gillian A Horne, Heather Morrison, David Irvine, Chinmay Munje

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Ross Kinstrie, Gillian A Horne, Heather Morrison, David Irvine, Chinmay Munje

Leukemia· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland Experience.
Yun Yi Tan, Bahaa Al-Bubseeree, David Irvine, Graham MacDonald, Grant McQuaker

Clin Genitourin Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
David A Irvine, Bin Zhang, Ross Kinstrie, Anuradha Tarafdar, Heather Morrison

Sci Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.
Renate Udo, Stéphanie Tcherny-Lessenot, Ruth Brauer, Paul Dolin, David Irvine

Pharmacoepidemiol Drug Saf· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the bone morphogenetic proteins in leukaemic stem cell persistence.
Parto Toofan, David Irvine, Lisa Hopcroft, Mhairi Copland, Helen Wheadon

Biochem Soc Trans· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, Michelle Padget, David A Irvine

Blood· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia stem cells display alterations in expression of genes involved in oxidative phosphorylation.
Krzysztof Flis, David Irvine, Mhairi Copland, Ravi Bhatia, Tomasz Skorski

Leuk Lymphoma· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hedgehog in hematologic malignancy.
David A Irvine, Mhairi Copland

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.
Paolo Gallipoli, Pat Shepherd, David Irvine, Mark Drummond, Tessa Holyoake

Br J Haematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study.
Ian Douglas, Liam Smeeth, David Irvine

Br J Clin Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors--a synthesis of clinical and laboratory data.
David A Irvine, Nicholas B Heaney, Tessa L Holyoake

Blood Rev· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden onset of substernal chest pain in a college student at rest.
David F Irvine, Wilson Crone

JAAPA· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of VX nerve agent hydrolysis products in wastewater effluents by ion chromatography with amperometric and conductivity detection.
Haishan Piao, Randall B Marx, Steven Schneider, David A Irvine, John Staton

J Chromatogr A· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of psychosocial support groups by parents who have a child with diabetes: a needs analysis.
Debra K Creedy, Tracey Ludlow, Jennie Beggs, Dianne Collis, David Irvine

Collegian· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis